Sugar intake during antibiotic use accelerates gut microbiome collapse

3 min read
Source: Prevention
Sugar intake during antibiotic use accelerates gut microbiome collapse
Photo: Prevention
TL;DR

A new study in Nature reveals that consuming sugary foods while taking antibiotics significantly worsens gut microbiome disruption. Researchers found that sugar intake during antibiotic treatment led to a 24% drop in bacterial diversity for every 100-gram increase in sweets, promoting the overgrowth of harmful Enterococcus bacteria. This effect was confirmed in mouse models, where sugar supplementation increased Enterococcus populations by up to 33-fold. The findings suggest that limiting sugar during antibiotic courses could protect gut health and improve clinical outcomes, particularly for cancer patients undergoing stem cell transplants.

Key points

  • Consuming sweets during antibiotic exposure is linked to a 24% decrease in gut microbiome diversity per 100-gram increase in sugar intake.
  • Sugar intake promotes the expansion of Enterococcus faecium, a pathobiont associated with severe infections and graft-versus-host disease in transplant patients.
  • Mouse experiments confirmed that sucrose supplementation increased Enterococcus populations by 16-fold by day three and 33-fold by day six after antibiotic exposure.
  • The study utilized precise dietary records from 173 cancer patients undergoing hematopoietic cell transplantation, tracking 9,419 meals and 1,009 stool samples.
  • Higher sugar consumption during treatment was associated with a 12% increased risk of mortality in transplant recipients.

Background

Previous research has established that diet influences gut microbiome composition, but studies often relied on recall-based surveys or focused on stable, healthy populations. This study addresses the gap in understanding how diet affects the microbiome during severe medical perturbations, such as chemotherapy and antibiotic use in cancer patients. It builds on earlier findings that fiber-rich diets support microbial recovery, while highlighting the specific risks of simple sugars during periods of antibiotic-induced dysbiosis.

How outlets are covering it

Prevention and CNN emphasize the clinical implications for cancer patients, noting that sugar intake exacerbates microbiome damage and increases mortality risk. New Scientist highlights the practical advice for patients to avoid sugary foods during antibiotic courses, noting that this is a low-toxicity intervention. The Nature article provides the detailed methodology, including Bayesian inference and mouse validation, underscoring the robustness of the findings. All sources agree on the core finding that sugar worsens antibiotic-induced dysbiosis, but differ in emphasis: Prevention focuses on the general health warning, CNN on the hospital context, and New Scientist on actionable dietary advice.

Why it matters

The findings suggest a simple, low-cost intervention—limiting sugar during antibiotic treatment—that could improve patient outcomes and reduce the risk of severe infections. This is particularly relevant for cancer patients undergoing stem cell transplants, where gut health is critical for survival. The study also raises questions about hospital dietary recommendations, such as the use of smoothies and milkshakes, which may need to be re-evaluated for patients on antibiotics.

What to watch

Researchers plan to conduct further studies in independent cohorts to generalize the findings and evaluate microbiota-sparing interventions. There is also interest in determining whether these effects apply to patients taking antibiotics outside of hospital settings, such as for common infections like ear infections. Future research may explore specific dietary strategies to protect the microbiome during antibiotic treatment.

Share this article

Want the full story? Read the original reporting

Read on Prevention